✦ LIBER ✦

365 A Phase 1b Open-label, Dose-escalation Study of the Safety and Pharmacology of GDC-0941 in Combination with Erlotinib in Patients with Advanced Solid Tumors

✍ Scribed by Lolkema, M.; Leong, S.; Voest, E.; Freas, E.; Shankar, G.; Brachmann, R.K.; Moss, R.A.; Stein, M.N.; Mergui-Roelvink, M.; Schellens, J.H.M.

Book ID: 123271576
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 78 KB
Volume: 48
Category: Article
ISSN: 0959-8049
DOI: 10.1016/S0959-8049(12)72163-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I dose-escalation and pharmacoki

A phase I dose-escalation and pharmacokinetic study of enzastaurin and erlotinib in patients with advanced solid tumors

✍ Sukhmani K. Padda; Yelena Krupitskaya; Laveena Chhatwani; George A. Fisher; Alex 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 281 KB

A Phase I, open-label, dose-escalation s

A Phase I, open-label, dose-escalation study of continuous once-daily oral treatment with afatinib in patients with advanced solid tumors

✍ Michael S. Gordon,David S. Mendelson,Mitchell Gross… 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 200 KB

Phase I dose-escalation study of tezacit

Phase I dose-escalation study of tezacitabine in combination with 5-fluorouracil in patients with advanced solid tumors

✍ Johanna C. Bendell; Joseph P. Eder; Jeffrey W. Clark; Panagiotis Fidias; Thomas 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 3 views

A phase 1 open-label, sequential dose-es

A phase 1 open-label, sequential dose-escalation study investigating the safety, tolerability, and pharmacokinetics of intravenous TLC388 administered to patients with advanced solid tumors

✍ Ghamande, Sharad; Lin, Chia-Chi; Cho, Daniel C.; Shapiro, Geoffrey I.; Kwak, Eun 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 318 KB

Phase 1, open-label, dose-escalation, an

Phase 1, open-label, dose-escalation, and pharmacokinetic study of STAT3 inhibitor OPB-31121 in subjects with advanced solid tumors

✍ Bendell, Johanna C.; Hong, David S.; Burris, Howard A.; Naing, Aung; Jones, Suza 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 189 KB

A Phase I, open-label, dose escalation s

A Phase I, open-label, dose escalation study of afatinib, in a 3-week-on/1-week-off schedule in patients with advanced solid tumors

✍ John Marshall,Jimmy Hwang,Ferry A. L. M. Eskens… 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 223 KB